| Year |
Citation |
Score |
| 2020 |
Berk M, Mohebbi M, Dean OM, Cotton SM, Chanen AM, Dodd S, Ratheesh A, Amminger GP, Phelan M, Weller A, Mackinnon A, Giorlando F, Baird S, Incerti L, Brodie RE, et al. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin. Bmc Medicine. 18: 16. PMID 31948461 DOI: 10.1186/S12916-019-1475-6 |
0.473 |
|
| 2018 |
Dean OM, Gliddon E, Van Rheenen TE, Giorlando F, Davidson SK, Kaur M, Ngo TT, Williams LJ. An update on adjunctive treatment options for bipolar disorder. Bipolar Disorders. PMID 29369487 DOI: 10.1111/Bdi.12601 |
0.384 |
|
| 2015 |
Quinn AL, Dean OM, Davey CG, Kerr M, Harrigan SM, Cotton SM, Chanen AM, Dodd S, Ratheesh A, Amminger GP, Phelan M, Williams A, Mackinnon A, Giorlando F, Baird S, et al. Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin. Early Intervention in Psychiatry. PMID 26542332 DOI: 10.1111/Eip.12280 |
0.485 |
|
| 2015 |
Dandash O, Harrison BJ, Adapa R, Gaillard R, Giorlando F, Wood SJ, Fletcher PC, Fornito A. Selective augmentation of striatal functional connectivity following NMDA receptor antagonism: implications for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 622-31. PMID 25141922 DOI: 10.1038/Npp.2014.210 |
0.465 |
|
| 2014 |
Giorlando F, Markanday S, Anderson A, Carpenter R, Berk M. Temporal order assessment in patients with bipolar disorder Procedia - Social and Behavioral Sciences. 126: 216-216. DOI: 10.1016/J.Sbspro.2014.02.381 |
0.587 |
|
| 2013 |
Berk M, Berk L, Davey CG, Moylan S, Giorlando F, Singh AB, Kalra H, Dodd S, Malhi GS. Treatment of bipolar depression. The Medical Journal of Australia. 199: S32-5. PMID 25370283 DOI: 10.5694/mja12.10611 |
0.409 |
|
| 2013 |
Giorlando F, Teister J, Dodd S, Udina M, Berk M. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs. Current Drug Safety. 8: 175-80. PMID 23841535 DOI: 10.2174/15748863113089990036 |
0.454 |
|
| 2013 |
Moore JW, Cambridge VC, Morgan H, Giorlando F, Adapa R, Fletcher PC. Time, action and psychosis: using subjective time to investigate the effects of ketamine on sense of agency. Neuropsychologia. 51: 377-84. PMID 22813429 DOI: 10.1016/J.Neuropsychologia.2012.07.005 |
0.494 |
|
| 2012 |
Dean OM, Data-Franco J, Giorlando F, Berk M. Minocycline: therapeutic potential in psychiatry. Cns Drugs. 26: 391-401. PMID 22486246 DOI: 10.2165/11632000-000000000-00000 |
0.522 |
|
| 2012 |
Moylan S, Giorlando F, Nordfjærn T, Berk M. The role of alprazolam for the treatment of panic disorder in Australia. The Australian and New Zealand Journal of Psychiatry. 46: 212-24. PMID 22391278 DOI: 10.1177/0004867411432074 |
0.425 |
|
| 2012 |
Dodd S, Malhi G, Tiller J, Schweitzer I, Hickie I, Khoo J, Basset D, Lyndon B, Mitchell P, Parker G, Fitzgerald P, Udina M, Singh A, Moylan S, Giorlando F, et al. O-10 - Safety monitoring guidelines for treatments for major depressive disorder European Psychiatry. 27: 1. DOI: 10.1016/S0924-9338(12)74110-X |
0.465 |
|
| 2011 |
Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, Fitzgerald PB, Udina M, Singh A, Moylan S, Giorlando F, et al. A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. The Australian and New Zealand Journal of Psychiatry. 45: 712-25. PMID 21888608 DOI: 10.3109/00048674.2011.595686 |
0.474 |
|
| 2011 |
Coull JT, Morgan H, Cambridge VC, Moore JW, Giorlando F, Adapa R, Corlett PR, Fletcher PC. Ketamine perturbs perception of the flow of time in healthy volunteers. Psychopharmacology. 218: 543-56. PMID 21603893 DOI: 10.1007/S00213-011-2346-9 |
0.562 |
|
| 2011 |
Berk M, Kapczinski FP, Andreazza AC, Dean O, Giorlando F, Maes MH, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger GP, McGorry PD, Malhi GS. Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors Neuroscience & Biobehavioral Reviews. 35: 804-817. PMID 20934453 DOI: 10.1016/J.Neubiorev.2010.10.001 |
0.449 |
|
| Show low-probability matches. |